1 ression of AR-regulated genes in response to androgen antagonists.

2 fic antigen gene promoter in response to the androgen antagonist bicalutamide, suggesting that Ebp1 d

3                 In vitro studies showed that androgen antagonist, bicalutamide, transiently elevated

4 ld-type male mice treated with flutamide, an androgen antagonist, exhibit reduced renal CYP2J5 levels

5 cement (n=7/group) were pre-treated with the androgen antagonist flutamide (15 mg/kg sc) or ethanol (

6 Finally, treatment of pregnant rats with the androgen antagonist flutamide eliminates the gender diff

7 was blocked by cotreatment with the specific androgen antagonist hydroxyflutamide.

8 at 13, to discriminate between androgen- and androgen antagonist-induced AR conformations.

9 e inhibitor; FemeraTM); (e) Flutamide + ATD (androgen antagonist plus steroidal aromatase inhibitor);